Prediction of radiotherapy response in cervix cancer by Raman spectroscopy

A pilot study

M. S. Vidyasagar, K. Maheedhar, B. M. Vadhiraja, Donald J. Fernendes, V. B. Kartha, C. Murali Krishna

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Radiotherapy is the choice of treatment for locally advanced stages of the cervical cancers, one of the leading female cancers. Because of intrinsic factors, tumors of same clinical stage and histological type often exhibit differential radioresponse. Radiotherapy regimen, from first fraction of treatment to clinical evaluation of response, spans more than 4 months. Clinical assessment by degree of tumor shrinkage is the only routinely practiced method to evaluate the tumor response. Hence, a need is created for development new methodologies that can predict the tumor response to radiotherapy at an early stage of the treatment which can lead to tailor-made protocols. To explore the feasibility of prediction of tumor radioresponse, Raman spectra of cervix cancer tissues that were collected before (malignant) and 24 h after patient was treated with 2nd fraction of radiotherapy (RT) were recorded. Data were analyzed by Principal Components Analysis (PCA) and results were correlated with clinical evaluation of radioresponse. Mean Raman spectra of RT tissues corresponding to different levels of tumor response, complete, partial, and no response, showed minute but significant variations. The unsupervised PCA of malignant tissues failed to provide any classification whereas RT spectra gave clear classification between responding (complete and partial response) and nonresponding conditions as well as a tendency of separation among responding conditions. These results were corroborated by supervised classification, by means of discrimination parameters: Mahalanobis distance and spectral residuals. Thus, findings of the study suggest the feasibility of Raman spectroscopic prediction of tumor radioresponse in cervical cancers.

Original languageEnglish
Pages (from-to)530-537
Number of pages8
JournalBiopolymers
Volume89
Issue number6
DOIs
Publication statusPublished - 01-06-2008

Fingerprint

Raman Spectrum Analysis
Radiotherapy
Uterine Cervical Neoplasms
Raman spectroscopy
Tumors
Neoplasms
Tissue
Principal component analysis
Principal Component Analysis
Raman scattering
Intrinsic Factor
Feasibility Studies
Therapeutics

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Biomaterials
  • Organic Chemistry

Cite this

Vidyasagar, M. S., Maheedhar, K., Vadhiraja, B. M., Fernendes, D. J., Kartha, V. B., & Krishna, C. M. (2008). Prediction of radiotherapy response in cervix cancer by Raman spectroscopy: A pilot study. Biopolymers, 89(6), 530-537. https://doi.org/10.1002/bip.20923
Vidyasagar, M. S. ; Maheedhar, K. ; Vadhiraja, B. M. ; Fernendes, Donald J. ; Kartha, V. B. ; Krishna, C. Murali. / Prediction of radiotherapy response in cervix cancer by Raman spectroscopy : A pilot study. In: Biopolymers. 2008 ; Vol. 89, No. 6. pp. 530-537.
@article{b78342ba61834a60a31b3afcc7005a56,
title = "Prediction of radiotherapy response in cervix cancer by Raman spectroscopy: A pilot study",
abstract = "Radiotherapy is the choice of treatment for locally advanced stages of the cervical cancers, one of the leading female cancers. Because of intrinsic factors, tumors of same clinical stage and histological type often exhibit differential radioresponse. Radiotherapy regimen, from first fraction of treatment to clinical evaluation of response, spans more than 4 months. Clinical assessment by degree of tumor shrinkage is the only routinely practiced method to evaluate the tumor response. Hence, a need is created for development new methodologies that can predict the tumor response to radiotherapy at an early stage of the treatment which can lead to tailor-made protocols. To explore the feasibility of prediction of tumor radioresponse, Raman spectra of cervix cancer tissues that were collected before (malignant) and 24 h after patient was treated with 2nd fraction of radiotherapy (RT) were recorded. Data were analyzed by Principal Components Analysis (PCA) and results were correlated with clinical evaluation of radioresponse. Mean Raman spectra of RT tissues corresponding to different levels of tumor response, complete, partial, and no response, showed minute but significant variations. The unsupervised PCA of malignant tissues failed to provide any classification whereas RT spectra gave clear classification between responding (complete and partial response) and nonresponding conditions as well as a tendency of separation among responding conditions. These results were corroborated by supervised classification, by means of discrimination parameters: Mahalanobis distance and spectral residuals. Thus, findings of the study suggest the feasibility of Raman spectroscopic prediction of tumor radioresponse in cervical cancers.",
author = "Vidyasagar, {M. S.} and K. Maheedhar and Vadhiraja, {B. M.} and Fernendes, {Donald J.} and Kartha, {V. B.} and Krishna, {C. Murali}",
year = "2008",
month = "6",
day = "1",
doi = "10.1002/bip.20923",
language = "English",
volume = "89",
pages = "530--537",
journal = "Biopolymers",
issn = "0006-3525",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

Vidyasagar, MS, Maheedhar, K, Vadhiraja, BM, Fernendes, DJ, Kartha, VB & Krishna, CM 2008, 'Prediction of radiotherapy response in cervix cancer by Raman spectroscopy: A pilot study', Biopolymers, vol. 89, no. 6, pp. 530-537. https://doi.org/10.1002/bip.20923

Prediction of radiotherapy response in cervix cancer by Raman spectroscopy : A pilot study. / Vidyasagar, M. S.; Maheedhar, K.; Vadhiraja, B. M.; Fernendes, Donald J.; Kartha, V. B.; Krishna, C. Murali.

In: Biopolymers, Vol. 89, No. 6, 01.06.2008, p. 530-537.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prediction of radiotherapy response in cervix cancer by Raman spectroscopy

T2 - A pilot study

AU - Vidyasagar, M. S.

AU - Maheedhar, K.

AU - Vadhiraja, B. M.

AU - Fernendes, Donald J.

AU - Kartha, V. B.

AU - Krishna, C. Murali

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Radiotherapy is the choice of treatment for locally advanced stages of the cervical cancers, one of the leading female cancers. Because of intrinsic factors, tumors of same clinical stage and histological type often exhibit differential radioresponse. Radiotherapy regimen, from first fraction of treatment to clinical evaluation of response, spans more than 4 months. Clinical assessment by degree of tumor shrinkage is the only routinely practiced method to evaluate the tumor response. Hence, a need is created for development new methodologies that can predict the tumor response to radiotherapy at an early stage of the treatment which can lead to tailor-made protocols. To explore the feasibility of prediction of tumor radioresponse, Raman spectra of cervix cancer tissues that were collected before (malignant) and 24 h after patient was treated with 2nd fraction of radiotherapy (RT) were recorded. Data were analyzed by Principal Components Analysis (PCA) and results were correlated with clinical evaluation of radioresponse. Mean Raman spectra of RT tissues corresponding to different levels of tumor response, complete, partial, and no response, showed minute but significant variations. The unsupervised PCA of malignant tissues failed to provide any classification whereas RT spectra gave clear classification between responding (complete and partial response) and nonresponding conditions as well as a tendency of separation among responding conditions. These results were corroborated by supervised classification, by means of discrimination parameters: Mahalanobis distance and spectral residuals. Thus, findings of the study suggest the feasibility of Raman spectroscopic prediction of tumor radioresponse in cervical cancers.

AB - Radiotherapy is the choice of treatment for locally advanced stages of the cervical cancers, one of the leading female cancers. Because of intrinsic factors, tumors of same clinical stage and histological type often exhibit differential radioresponse. Radiotherapy regimen, from first fraction of treatment to clinical evaluation of response, spans more than 4 months. Clinical assessment by degree of tumor shrinkage is the only routinely practiced method to evaluate the tumor response. Hence, a need is created for development new methodologies that can predict the tumor response to radiotherapy at an early stage of the treatment which can lead to tailor-made protocols. To explore the feasibility of prediction of tumor radioresponse, Raman spectra of cervix cancer tissues that were collected before (malignant) and 24 h after patient was treated with 2nd fraction of radiotherapy (RT) were recorded. Data were analyzed by Principal Components Analysis (PCA) and results were correlated with clinical evaluation of radioresponse. Mean Raman spectra of RT tissues corresponding to different levels of tumor response, complete, partial, and no response, showed minute but significant variations. The unsupervised PCA of malignant tissues failed to provide any classification whereas RT spectra gave clear classification between responding (complete and partial response) and nonresponding conditions as well as a tendency of separation among responding conditions. These results were corroborated by supervised classification, by means of discrimination parameters: Mahalanobis distance and spectral residuals. Thus, findings of the study suggest the feasibility of Raman spectroscopic prediction of tumor radioresponse in cervical cancers.

UR - http://www.scopus.com/inward/record.url?scp=42349083870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42349083870&partnerID=8YFLogxK

U2 - 10.1002/bip.20923

DO - 10.1002/bip.20923

M3 - Article

VL - 89

SP - 530

EP - 537

JO - Biopolymers

JF - Biopolymers

SN - 0006-3525

IS - 6

ER -